https://clinicaltrials.gov/ct2/show/NCT03181932?recrs=abdf&type=Intr&cond=Cystic+Fibrosis&lupd_s=03%2F21%2F2019&lupd_d=14
Conditions : MRSA; Cystic Fibrosis
Interventions : Drug: Vancomycin inhalation powder; Drug: Placebo inhalation powder
Sponsor : Savara Inc.
Recruiting
A Study of AeroVanc for the Treatment of MRSA Infection in CF Patients
NCT03181932
Fri, 09 Jun 2017 12:00:00 EDT
Last Update Posted: 04/04/19 07:50AM
